Skip to main content
Jason Gold, MD, General Surgery, Boston, MA, Veterans Affairs Boston Healthcare System

JasonSamuelGoldMD

General Surgery Boston, MA

Surgical Oncology (Other than Breast)

Associate Professor of Surgery Harvard Medical School, Chief of Surgical Oncology VA Boston HCS

Dr. Gold is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Gold's full profile

Already have an account?

Education & Training

  • Memorial Sloan Kettering Cancer Center2004 - 2006
  • Yale-New Haven Hospital
    Yale-New Haven HospitalResidency, General Surgery, 1997 - 2004
  • Yale University School of Medicine
    Yale University School of MedicineClass of 1997
  • Dartmouth College
    Dartmouth CollegeB.A., Philosophy and Biochemistry, Magna Cum Laude, 1989 - 1993

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2007 - 2022
  • NY State Medical License
    NY State Medical License 2004 - 2007
  • American Board of Surgery Surgery

Awards, Honors, & Recognition

  • ASCO Foundation Merit Award 2006
  • Fellow (FACS) American College of Surgeons

Publications & Presentations

PubMed

Journal Articles

  • Population-Based Outcome of Stage IA-IIA Resected Gastric Adenocarcinoma: Who Should Get Adjuvant Treatment?  
    Gold JS, Al Natour RH, Saund MS, Yoon C, Sharma AM, Huang Q, Boosalis VA, Whang EE, Annals of Surgical Oncology, 1/1/2013
  • Tumor size and depth predict rate of lymph node metastasis in colon carcinoids and can be used to select patients for endoscopic resection.  
    Al Natour RH, Saund MS, Sanchez VM, Sharma AM, Huang Q, Boosalis VA, Gold JS, Journal of Gastrointestinal Surgery, 1/1/2012
  • Pancreatic acinar-like adenocarcinoma of the proximal stomach invading the esophagus  
    Huang Q, Gold JS, Shi, J, Fan X, Wu H, Feng A, Zhou Q, Human Pathology, 1/1/2012
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Population-based outcome of Stages IA-IIA resected gastric adenocarcinoma: who should get adjuvant treatment?
    Gold JS, Al Natour RH, Saund MS, Yoon C, Sharma AM, Huang Q, Boosalis VA, Whang EE, Gastrointestinal Cancers Symposium; Society of Surgical Oncology (2012), 1/1/2012
  • Requirement of the CCL20-CCR6 Pathway in the Development and Progression of Intestinal Adenomas and Colorectal Adenocarcinoma
    Gold JS, Pai C, Prabhala RH, Munshi NC, Academic Surgical Congress, 1/1/2012
  • Lack of Th17 cells does not appear to have a major impact on intestinal tumorigenesis in MIN mice
    Gold JS, Pai C, Prabhala RH, Munshi NC, Academic Surgical Congress, 1/1/2011
  • Join now to see all

Lectures

  • Reasearch opportunities in the VA 
    Surgery Research Fellows Conference, Brigham and Womens' Hospital - 1/1/2012
  • Clinical Outcomes and Biomarkers 
    Sixth Annual Academic Surgical Congress - 1/1/2011
  • Multidisciplinary treatment of hepatocellular carcinoma 
    Department of Surgery Grand Rounds, Brigham and Women's Hospital - 1/1/2011
  • Join now to see all

Press Mentions

  • Brockton's Health Centers Don't Require COVID Vaccines for Staff, but Are Considering It
    Brockton's Health Centers Don't Require COVID Vaccines for Staff, but Are Considering ItAugust 28th, 2021

Professional Memberships

Hospital Affiliations